FHB
ALXN

First Hawaiian Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

First Hawaiian Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,908
Closed -$351K – 892
2021
Q2 		$351K Sell
1,908
-688
-27% -$118K 0.01% 655
2021
Q1 		$397K Hold
2,596
– – 0.02% 621
2020
Q4 		$406K Sell
2,596
-770
-23% -$98.9K 0.02% 556
2020
Q3 		$385K Sell
3,366
-701
-17% -$75.6K 0.02% 513
2020
Q2 		$456K Buy
4,067
+661
+19% +$70.2K 0.02% 451
2020
Q1 		$305K Sell
3,406
-440
-11% -$43.2K 0.02% 533
2019
Q4 		$416K Buy
3,846
+435
+13% +$46.5K 0.02% 550
2019
Q3 		$334K Buy
3,411
+670
+24% +$75.5K 0.02% 613
2019
Q2 		$359K Sell
2,741
-1,059
-28% -$136K 0.02% 580
2019
Q1 		$514K Buy
3,800
+1,105
+41% +$137K 0.03% 432
2018
Q4 		$262K Buy
2,695
+1,963
+268% +$232K 0.02% 628
2018
Q3 		$102K Buy
+732
New +$91.8K 0.01% 938

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return